Genmab — April 2021

JørgenVarnæs

Do you know when the “bridging program” ends? Sounds like Q3

E_L

it depends on when they stop offering it i guess; it was approved Q3 last year, a 12 month program, so Q3 this year first will fall of. But those that got into the program in Q1 may have until Q1 next year?

JørgenVarnæs

It certainly sounds like there is a long tail of “free sales” in those numbers

E_L

on the %, numbers just for easy illustration- imagine they first thought H1 25M sales and H2 75M ; H2 would be 75% of sales.

E_L

Now they think H1 50M sales and H2 90M ; H2 would be
64% of sales.

E_L

Sanofi: First-quarter Sarclisa sales were €34 million driven by
additional country launches. First-quarter sales in the U.S. and in Europe were €12 million and €13 million, respectively.
In Rest of the World sales (€9 million) were driven by a strong performance in Japan.

JørgenVarnæs

So, basically what they are saying is H1 paid sales have surprised us, but we leave guidance for H2 paid sales unchanged - that is why this “percentage sales” will decrease...?

JørgenVarnæs

Makes sense in a very arse-backwards-we-insist-on-not-making-sense sort of way...

E_L

almost; in my example H2 also went up versus expectation, just not as much as H1

E_L

in real numbers, lets say Q2 will grow to for example 75M. Then H1 ends up at 125M. To make their % correct we would need 230M in H2 to get to 65%. So that would total full year sales at 355M. So i think we can use something like that for now as 2021 estimate

E_L

@ 09.42 it could be a 'long' tail, but given that 70% is already paid, it will not be a 'large' tail

JørgenVarnæs

Sorry. Had to step out to learn the missus to handle the motorbike. Your calcs defininately sound right. Thanks for that!

JørgenVarnæs

Learn/teach.

nohope

What a waste - How about teaching her the lawnmover instead ?

JørgenVarnæs

That I cannot - don’t know where to find it

gentogen

Thanks EL.

E_L

Genmab wins our CEO performance ranking: Rescue plan turned into a success https://ugebrev.dk/ledelse/genmab-wins-our-ceo-performance-ranking-rescue-plan-turned-into-a-success/

Bulder

Asco abstract titles i eftermiddag. 10.00 am ET må være kl. 15 da ti.

Bulder

Jeg opgiver. Hver eneste søgning giver resultater fra 2019 eller 2020. Håber andre har bedre held.

deleted-user

Bulder - er det ikke 16.00?